TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Intervention acceptability
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Bone mineral density of femur bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Data quality dimensions prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency of AI tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of AI tool detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Edinburgh Claudication Questionnaire score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ankle-Brachial Index (ABI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stimulation intensity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Drug-Induced Liver Injury (DILI)
Endpoint domain: Adverse events/effects
Primary endpoint: Response to treatment measured by the composite response of 2-grade improvement on investigator's live assessment (ILA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NRS pain score from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of suspected unexpected serious adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with clinically significant changes in laboratory assessment data
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events that leads to the termination or suspension of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Total amount of epidural local anesthetics consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knowledge levels of Midwives and Nurses regarding ERAS Protocols
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: median Progressive Free Survival (mPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change in Movement Counts Per 15 Seconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Gross Motor Performance Using the Gross Motor Function Measure-88 Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Caregiver Perception of Their Child's Mastery Motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BMI (kg/cm2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parathyroid gland identification rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Testosterone response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Timeline Follow-back (TLFB)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Activity Minutes/Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ultrasound enthesitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of patients treated with olaparib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of olaparib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in crestal bone height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Development of First New Radiologic or Clinical Evidence of MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of rDEN2Δ30-7169
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in assessment duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Difference in patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difference in cost effectiveness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PFC-PPC effective connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PFC-PPC activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic accuracy of AI model for venous disease detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low anterior resection syndrome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of enrolled cases
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients free from first atrial tachyarrhythmia recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reliability of clinical examination of pupils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: measured stress level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Early Rate of CTCAE GI Toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Scores on the Forward Step Down Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of patient pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of gait parameters (step length)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of patient function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dressing wear time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise dropout rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Efficacy of preoperative analgesics on inferior alveolar nerve block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Stability of lower anterior teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention on PrEP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Usage Hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in C-Reactive Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in Interleukin-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Statin prescription rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in cognitive function global deficit score (GDS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cannabis-abstinent days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Music's Impact on Mental Health and Well-Being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in the Importance of Music in Participant's Life
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Incidence of adverse events assessed by CTCAE v 5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of necessity for dose adjustments, delay or early cessation
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life regarding daily activities and emotional health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life regarding level of discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reliability/validity of questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes of vital signs from 1 hour after infusion to day 28±3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of complete blood count (CBC) from day 1 to day 28±3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Skin Blood Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Non-operative treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and tolerability of the therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Level of intraoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinician-Completed Congenital DM1 Rating Scale (CDM1-RS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of weigh/overweight subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Mediterranean Diet (MD) adherence
Endpoint domain: Life impact
Endpoint subdomain: Nutritional habits
Primary endpoint: Change in physiological parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with abnormal MRI results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with clinically significant changes in physical and neurological examination results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measurement of levels of specific antibodies against a-synuclein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Triglycerides Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HDL-C Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: LDL-C Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Apolipoprotein A-I Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Apolipoproteina B Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of type II Diabetes Mellitus diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: headache outcome HIT-6
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Standardised uptake values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mosquito infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in pulmonary health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Detection of Myocardial Ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anxiety measured by the State Trait Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety measured by the Amsterdam Preoperative Anxiety and Information Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Need for information measured by the Amsterdam Preoperative Anxiety and Information Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health literacy measured by The Health Literacy Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction measured by a patient satisfaction survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Categorical cure of anterior chamber cell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients in glucocorticoid-free remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depression, anxiety, and Stress Scale (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mindful Attention awareness Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Opioid Craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scales (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear film surface quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in primary motor cortical beta oscillations during cued arm reaching
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in primary motor cortical beta oscillations during arm flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: self-reported UI change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: the impact of UI on quality of life change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: adherence to PFMT programme change 1
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: adherence to PFMT programme change 2
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain Score (VAS) 48hr rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Score (VAS) 48hr movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of postvitrectomy complication
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients treated for in-hospital cardiac arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) motor parts II and III
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of COVID-19 viral infectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of piperacillin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: AUCGIR 0-6h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCGIR 6-24h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vancouver Scar Scale (VSS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Quality of life - Sf 12
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: modified Rankin Scale score (mRS) 0-1
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: plasma concentrations of cotrimoxazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of coccidian parasites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of subjects achieving EASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: preoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: live birth after ART
Endpoint domain: Mortality/survival
Primary endpoint: PrRelapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extreme outside therapeutic range
Endpoint domain: Adverse events/effects
Primary endpoint: Rhinoconjunctivitis quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: NO pain at follow up
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Western Ontario and McMaster Universities Arthritis Index (WOMAC) osteoarthritis index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: swelling joint count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: tenderness joint count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adverse Events (AE) after CT071 infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial ventilation effectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Fetal/neonatal/infant outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Objective remission rate (ORR)
Endpoint domain: Mortality/survival
Primary endpoint: Crowdsourced rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in energy expenditure using direct calorimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in energy expenditure using indirect calorimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of life (MHQoL-7)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Microvascular Hemoglobin Content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2 peak oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maintained Symptomatic Stenosis Response at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiographic Stenosis Response at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression scale - Severity (CGI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum LH level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Incidence of floating hip injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Time to receipt of postpartum care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fugl-Meyer Assessment of Upper Extremity (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Range of Motion Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Numeric pain rating scale (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation Dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in FEV1 from baseline to 10 minutes after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in FVC from baseline to 10 minutes after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in FEF25-75 from baseline to 10 minutes after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total number of ILI cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical Occlusal Adjustment Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hyperglycaemia Avoidance Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: General Anxiety Disorder-7 (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of physical restraints use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Chest temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time In Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extension of obturating material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Time-in-Range (TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCC response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants Cured of Trichomonas Vaginalis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Gait analysis results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State Anxiety Inventory Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trait Anxiety Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coronavirus Anxiety Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Registration Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: marginal bone level (MBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in COM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in COP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of self-report T-ACE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular chlamydia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Crestal bone level (CBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse in Cardiotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes